◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Novo Nordisk A/S (NVO)

Name: Novo Nordisk A/S（NVO）— 财务报表历史
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

来自官方财务报表的收入、利润与现金流历史。

HEALTHCARE · 华尔街（美国） · 最近更新： 2026-09-19

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy.

关键数据

市值: $191 billion
收入（截至 2025-12-31 财年）: DKK 309.1B
净利润: DKK 102.4B
毛利率: 81.0%
净利率: 33.1%

查看交互式图表与完整报表 → 估值模型 (DCF) →

年度利润表

利润表	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
总收入	DKK 329.4B	DKK 309.1B	DKK 290.4B	DKK 232.3B	DKK 177.0B	DKK 140.8B	DKK 126.9B	DKK 122.0B	DKK 111.8B	DKK 111.7B	DKK 111.8B	DKK 107.9B	DKK 88.8B	DKK 83.6B	DKK 78.0B	DKK 66.3B	DKK 60.8B	DKK 51.1B	DKK 45.7B	DKK 41.9B	DKK 38.8B
毛利	DKK 265.7B	DKK 250.3B	DKK 245.9B	DKK 196.5B	DKK 148.5B	DKK 117.1B	DKK 106.0B	DKK 101.9B	DKK 94.2B	DKK 94.1B	DKK 94.6B	DKK 91.7B	DKK 74.2B	DKK 69.4B	DKK 64.6B	DKK 53.8B	DKK 49.1B	DKK 40.6B	DKK 35.5B	DKK 32.1B	DKK 29.2B
毛利率%	80.7%	81.0%	84.7%	84.6%	83.9%	83.2%	83.5%	83.5%	84.2%	84.2%	84.6%	85.0%	83.6%	83.1%	82.7%	81.0%	80.8%	79.6%	77.8%	76.6%	75.3%
营业利润（EBIT）	DKK 142.1B	DKK 127.7B	DKK 128.3B	DKK 102.6B	DKK 74.8B	DKK 58.6B	DKK 54.1B	DKK 52.5B	DKK 47.2B	DKK 49.0B	DKK 48.4B	DKK 49.4B	DKK 34.5B	DKK 31.5B	DKK 29.5B	DKK 22.4B	DKK 18.9B	DKK 14.9B	DKK 12.4B	DKK 9.0B	DKK 9.1B
营业利润率%	43.1%	41.3%	44.2%	44.2%	42.3%	41.6%	42.6%	43.0%	42.2%	43.8%	43.3%	45.8%	38.8%	37.7%	37.8%	33.7%	31.1%	29.2%	27.2%	21.4%	23.5%
净利	DKK 116.4B	DKK 102.4B	DKK 101.0B	DKK 83.7B	DKK 55.5B	DKK 47.8B	DKK 42.1B	DKK 39.0B	DKK 38.6B	DKK 38.1B	DKK 37.9B	DKK 34.9B	DKK 26.5B	DKK 25.2B	DKK 21.4B	DKK 17.1B	DKK 14.4B	DKK 10.8B	DKK 9.7B	DKK 8.5B	DKK 6.5B
净利润率 %	35.4%	33.1%	34.8%	36.0%	31.4%	33.9%	33.2%	31.9%	34.5%	34.1%	33.9%	32.3%	29.8%	30.1%	27.5%	25.8%	23.7%	21.1%	21.2%	20.4%	16.7%
EBITDA	—	DKK 156.7B	DKK 147.9B	DKK 114.6B	DKK 76.8B	DKK 65.4B	DKK 59.3B	DKK 54.4B	DKK 51.6B	DKK 52.0B	DKK 51.1B	DKK 46.5B	DKK 37.6B	DKK 35.4B	DKK 30.6B	DKK 24.9B	DKK 21.3B	DKK 17.8B	DKK 14.9B	DKK 12.0B	DKK 11.3B
每股收益（EPS）	DKK 26.20	DKK 23.03	DKK 22.63	DKK 18.62	DKK 12.22	DKK 10.37	DKK 9.00	DKK 8.19	DKK 7.97	DKK 7.69	DKK 7.48	DKK 6.76	DKK 5.03	DKK 4.67	DKK 3.88	DKK 3.00	DKK 2.46	DKK 1.78	DKK 1.55	DKK 1.34	DKK 1.00
已发行股数 (M)	—	4,448M	4,463M	4,495M	4,545M	4,606M	4,680M	4,757M	4,849M	4,956M	5,070M	5,157M	5,260M	5,387M	5,517M	5,701M	5,855M	6,043M	6,226M	6,357M	6,459M

来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。

资产负债表、现金流、季度数据与完整财务比率见 NVO 交互式查看器。 /companies/us/NVO

类似公司

本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。

English version →全部股票

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.